KLDO (Kaleido Biosciences) DeferredTaxAndRevenue: $0.83 Mil (As of Dec. 2021)


What is Kaleido Biosciences DeferredTaxAndRevenue?

Kaleido Biosciences KLDO DeferredTaxAndRevenue is $0.83 Mil as of Dec. 2021.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Kaleido Biosciences's current deferred tax and revenue for the quarter that ended in Dec. 2021 was $0.83 Mil.

Kaleido Biosciences DeferredTaxAndRevenue Related Terms

Kaleido Biosciences DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences DeferredTaxAndRevenue Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.50 0.83

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.28 0.19 0.15 0.83
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.83 Mil mean?
Kaleido Biosciences (KLDO) has a DeferredTaxAndRevenue of $0.83 Mil as of Dec. 2021. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Kaleido Biosciences.
Is Kaleido Biosciences' DeferredTaxAndRevenue too high?
Kaleido Biosciences' current DeferredTaxAndRevenue is $0.83 Mil.
How does Kaleido Biosciences' DeferredTaxAndRevenue compare to NPTX and GSTC?
Kaleido Biosciences' DeferredTaxAndRevenue of $0.83 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Kaleido Biosciences. Kaleido Biosciences's current DeferredTaxAndRevenue is $0.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current DeferredTaxAndRevenue of $0.83 Mil. The current DeferredTaxAndRevenue is $0.83 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current DeferredTaxAndRevenue is $0.83 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.